loadpatents
name:-0.042255163192749
name:-0.032756090164185
name:-0.0078089237213135
Bigner; Darell Patent Filings

Bigner; Darell

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bigner; Darell.The latest application filed is for "combination therapy of immunotoxin and checkpoint inhibitor".

Company Profile
7.34.41
  • Bigner; Darell - Mebane NC
  • Bigner; Darell - Durham NC
  • Bigner; Darell - Chapel Hill NC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods for predicting tumor response to immunotherapy
Grant 11,428,691 - Ashley , et al. August 30, 2
2022-08-30
Compositions and methods for activating antigen presenting cells with chimeric poliovirus
Grant 11,331,343 - Nair , et al. May 17, 2
2022-05-17
Somatic mutations in ATRX in brain cancer
Grant 11,254,988 - Yan , et al. February 22, 2
2022-02-22
Combination Therapy of Immunotoxin and Checkpoint Inhibitor
App 20210338811 - Bigner; Darell ;   et al.
2021-11-04
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma
App 20210317532 - Vogelstein; Bert ;   et al.
2021-10-14
Combination therapy of immunotoxin and checkpoint inhibitor
Grant 11,065,332 - Bigner , et al. July 20, 2
2021-07-20
Neoadjuvant Cancer Treatment With Immunotoxin And Checkpoint Inhibitor Combination
App 20210214442 - BIGNER; Darell ;   et al.
2021-07-15
Neoadjuvant Cancer Treatment
App 20210106633 - Bigner; Darell ;   et al.
2021-04-15
Methods For Predicting Tumor Response To Immunotherapy
App 20210063398 - Ashley; David ;   et al.
2021-03-04
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
Grant 10,837,064 - Vogelstein , et al. November 17, 2
2020-11-17
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
Grant 10,704,108 - Vogelstein , et al.
2020-07-07
Methods for rapid and sensitive detection of hotspot mutations
Grant 10,633,711 - Yan , et al.
2020-04-28
Oligodendroglioma drive genes
Grant 10,619,217 - Vogelstein , et al.
2020-04-14
Compositions And Methods For Activating Antigen Presenting Cells With Chimeric Poliovirus
App 20190167718 - Nair; Smita ;   et al.
2019-06-06
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma
App 20190106752 - Vogelstein; Bert ;   et al.
2019-04-11
Somatic Mutations In Atrx In Brain Cancer
App 20180334726 - Yan; Hai ;   et al.
2018-11-22
Combination Therapy Of Immunotoxin And Checkpoint Inhibitor
App 20180311346 - Bigner; Darell ;   et al.
2018-11-01
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma
App 20180282821 - Vogelstein; Bert ;   et al.
2018-10-04
Methods for using antibodies for 3' iso-LM1 and 3', 6'-iso-LD1tumor gangliosides
Grant 10,052,382 - Bigner , et al. August 21, 2
2018-08-21
Oligodendroglioma Drive Genes
App 20180195132 - Vogelstein; Bert ;   et al.
2018-07-12
Somatic mutations in ATRX in brain cancer
Grant 9,982,306 - Yan , et al. May 29, 2
2018-05-29
Oligodendroglioma drive genes
Grant 9,873,917 - Vogelstein , et al. January 23, 2
2018-01-23
Methods For Rapid And Sensitive Detection Of Hotspot Mutations
App 20170247765 - Yan; Hai ;   et al.
2017-08-31
Homozygous and heterozygous IDH1 gene-defective human astrocytoma cell lines
Grant 9,695,400 - Yan , et al. July 4, 2
2017-07-04
Medulloblastoma genes as targets for diagnosis and therapeutics
Grant 9,695,479 - Vogelstein , et al. July 4, 2
2017-07-04
Human bispecific EGFRvIII antibody and CD3 engaging molecules
Grant 9,676,858 - Bigner , et al. June 13, 2
2017-06-13
Mutations Define Clinical Subgroups Of Gliomas
App 20160340741 - Yan; Hai ;   et al.
2016-11-24
Dual specific immunotoxin for brain tumor therapy
Grant 9,492,564 - Bigner , et al. November 15, 2
2016-11-15
Antibodies for Tumor Gangliosides
App 20160272730 - Bigner; Darell ;   et al.
2016-09-22
Antibody for 3'-isoLM1 and 3',6'-iso-LD1 gangliosides
Grant 9,441,048 - Bigner , et al. September 13, 2
2016-09-13
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
Grant 9,353,418 - Vogelstein , et al. May 31, 2
2016-05-31
Anti-Podoplanin Antibodies and Methods of Use
App 20150368353 - BIGNER; Darell ;   et al.
2015-12-24
Homozygous and heterozygous IDH1 gene-defective cell lines derived from human colorectal cells
Grant 9,074,221 - Yan , et al. July 7, 2
2015-07-07
HUMAN BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES
App 20150132306 - Bigner; Darell ;   et al.
2015-05-14
Concurrent Chemotherapy and Immunotherapy
App 20150118181 - Sampson; John H. ;   et al.
2015-04-30
Dual Specific Immunotoxin for Brain Tumor Therapy
App 20140322248 - BIGNER; Darell ;   et al.
2014-10-30
Somatic Mutations In Atrx In Brain Cancer
App 20140227271 - Yan; Hai ;   et al.
2014-08-14
Oligodendroglioma Drive Genes
App 20140221219 - Vogelstein; Bert ;   et al.
2014-08-07
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma
App 20140187764 - VOGELSTEIN; Bert ;   et al.
2014-07-03
Homozygous And Heterozygous Idh1 Gene-defective Cell Lines Derived From Human Colorectal Cells
App 20140147919 - Yan; Hai ;   et al.
2014-05-29
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
Grant 8,685,660 - Vogelstein , et al. April 1, 2
2014-04-01
Anti-podoplanin Antibodies And Methods Of Use
App 20140017266 - Bigner; Darell ;   et al.
2014-01-16
Antibodies For Tumor Gangliosides
App 20140010829 - Bigner; Darell ;   et al.
2014-01-09
Homozygous And Heterozygous Idh1 Gene-defective Human Astrocytoma Cell Lines
App 20130252330 - Yan; Hai ;   et al.
2013-09-26
Dual Specific Immunotoxin for Brain Tumor Therapy
App 20130022598 - Bigner; Darell ;   et al.
2013-01-24
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma
App 20120202207 - VOGELSTEIN; Bert ;   et al.
2012-08-09
Effects Of Idh1 And Idh2 Mutations On The Cellular Metabolome
App 20120202883 - Hai; Yan ;   et al.
2012-08-09
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma
App 20110229479 - Vogelstein; Bert ;   et al.
2011-09-22
Anti-Tumor Antibodies
App 20100047164 - Bigner; Darell ;   et al.
2010-02-25
Dual Specific Immunotoxin for Brain Tumor Therapy
App 20090269343 - Bigner; Darell ;   et al.
2009-10-29
Antibodies And Immunotoxins That Target Human Glycoprotein Nmb
App 20090252750 - Kuan; Chien-Tsun ;   et al.
2009-10-08
Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
Grant 7,129,332 - Pastan , et al. October 31, 2
2006-10-31
Anti-egfrvIII scfvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
App 20030211097 - Pastan, Ira ;   et al.
2003-11-13
Structural alterations of the EGF receptor genes in human tumors
Grant 6,455,498 - Vogelstein , et al. September 24, 2
2002-09-24
Method for diagnosing glioma associated with structural alterations of the EGF receptor gene in human tumors
Grant 6,127,126 - Vogelstein , et al. October 3, 2
2000-10-03
Structural alterations of the EGF receptor gene in human tumors
Grant 5,981,725 - Vogelstein , et al. November 9, 1
1999-11-09
Structural alterations of the EGF receptor gene in human gliomas
Grant 5,814,317 - Vogelstein , et al. September 29, 1
1998-09-29
Assays for the presence of a mutant EGF receptor
Grant 5,710,010 - Vogelstein , et al. January 20, 1
1998-01-20
Structural alterations of the EGF receptor gene in human gliomas
Grant 5,401,828 - Vogelstein , et al. March 28, 1
1995-03-28
Antibodies specific for type II mutant EGTR
Grant 5,212,290 - Vogelstein , et al. May 18, 1
1993-05-18
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed